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ABSTRACT
High concentrations of lipids in ascites fluid caused by perito
neal carcinomatosis have been described recently. Since their
nature has not yet been clarified, we isolated ascitic lipids from
25 patients with various neoplasms for further characterization.
After chromatography on Sephadex G-100 gels, the ascitic lipids
were fractionated on a Biogel A-5m column in three peaks. The
second and third peaks were identified as low and high density
lipoproteins, which were most likely of plasmatic origin, and
represented the major amounts of ascitic lipids. The first peak
was eluted in the void volume, indicating a molecular weight over
5 million. It consisted, on the average, of 65.3% protein, 16.2%
triglycÃ©rides, 7.4% phospholipids, and 7.0% cholesterol. In a
CsCI gradient, this protein-lipid complex floated in the density
range from 1.128 to 1.181 g/ml. Sodium dodecyl sulfate:
polyacrylamide gel electrophoresis separated up to 11 protein
subunits (M, 29,000 to 97,000), and electron microscopy re
vealed globular particles of 36 to 64 nm in diameter. The mac-
romolecular complex showed no immunological reaction against
anti-a- and anti-/3-lipoproteins, but a single precipitation line
against anti-liver-specific lipoprotein was seen.
The biochemical characteristics of this protein-lipid complex
proved to have a close relationship to liver-specific lipoprotein. It
is most likely derived from cell membranes of the peritoneum
detached by carcinomatosis.
INTRODUCTION
Ascitic lipids may form complexes with proteins, and consid
erable amounts of sodium deoxycholate (115 mg/mg protein)
are necessary to separate cholesterol and triacylglycerol from
the protein moiety by gel filtration (1). All density classes of
lipoproteins corresponding to their plasmatic counterparts could
be isolated from ascites fluid (2-5). Suzuki ef a/. (1) separated
human ascites plasma LDL2 by ultracentrifugation in two sub
classes and determined quantitatively their relative protein and
lipid composition. They differed from plasma LDL in that high
contents of triacylglycerol of about 20% were found. Molecular
weight and antigenic activities were similar to those of plasmatic
lipoproteins. From corresponding electrophoretic patterns be
tween Ehrlich ascites tumor and plasma apoproteins (2), it was
concluded that ascitic lipoproteins may be derived from plasmatic
lipoproteins (3) synthesized in the liver and intestine of the tumor-
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bearing host (4, 5). However, distinct differences to correspond
ing plasma lipoproteins have been observed by the same authors
(4).
Recently high lipid concentrations have been described in
tumor ascites fluid (6, 7). The nature and origin of these lipids
have not yet been investigated. Therefore, it was the aim of the
present study to isolate and to characterize lipids from ascitic
fluid caused by various neoplasms.
MATERIALS AND METHODS
Patients. We studied a total of 25 patients from 38 to 74 yr of age
with peritoneal carcinomatosis and ascites fluid. The group consisted of
three male patients with adenocarcinoma of the stomach, two patients
each with gallbladder (female) and pancreas cancers (male), and nine
female patients each with advanced carcinoma of the ovary (Stages III
and IV; FÃ©dÃ©rationI ternationale de GynÃ©cologieet d'ObstÃ©trique) and
metastatic breast cancer (TaNtM^to T4N3Mib; International Union against
Cancer). Diagnoses were confirmed by radiological, sonographic, endo
scopie, computer tomographic, histological, and cytological methods or
by autopsy.
Ascites fluid was collected from living patients before any chemother
apy was started. One patient with chylous and four patients with ma-
croscopically hemorrhagic ascites were excluded from the study.
Chemical Assays. Protein was determined with the Biuret reagent
(8), and microquantities for electrophoresis were measured by the
method of Lowry ef a/. (9) after precipitation of the proteins with trichlo-
roacetic acid.
Total cholesterol and triglycÃ©ridedeterminations were performed en-
zymatically with commercial test kits (Boehringer, Mannheim, Federal
Republic of Germany) (10, 11).
Phospholipids were determined in chlorofornrmethanol extracts (3:1,
v/v) by colorimetrie phosphorous determination (12). Further fractionation
was achieved by thin-layer chromatography on 20- x 20-cm glass plates
coated with silica gel (Merck, Darmstadt, Federal Republic of Germany).
Chloroform:methanol:ammonia (13:5:1, v/v/v) was used as solvent sys
tem. The separated phospholipids were made visible with iodine vapor
and stained individually. Cardiolipin, phosphatidylcholine, sphingomyelin,
and phosphatidylinositol served as reference substances.
The accuracy was tested by Precilip E. L. standard sera (Boehringer).
Fractionation of Ascites Fluid. The fractionation of ascitic fluid at
4Â°Cwas started within 1 h after the collection. Samples were passed
through a Selecta No. 11171/2 filter (Schleicher-Schiill, Dassel, Federal
Republic of Germany) in order to remove cells and cellular debris of 5 to
10 ÃŸtnin diameter. To avoid bacterial growth and enzymatic degradation,
0.2 g of sodium azide (NaN3) and 0.05 mmol of PMSF in 50% aqueous
isopropanol were added per 1000 ml of ascites fluid. The PMSF solution
was always freshly prepared before it was added to the ascitic fluid,
since premature inactivation occurred unless it was immediately brought
into contact with proteases. Concentration to about one-tenth of the
original volume was performed in a stirred cell (Amicon, Witten, Federal
Republic of Germany; Models 402 and 52) using PM 10 membranes.
Four-mi specimens were incubated at 20Â°C with 0.4 ^Ci of ethanolic
[1,2-3H]cholesterol (New England Nuclear, Boston, MA), which is incor
porated into protein:lipid complexes (13) and serves as an easily detect-
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able, highly sensitive, but not quantitative marker of the lipid moiety.
Afterwards gel chromatography was performed on a 100- x 2.5-cm
Sephadex G-100 column. The amounts applied to the column did not
exceed 300 mg of protein, and the flow was less than 16 ml/h. The
elution buffer contained 0.15 M NaCI, disodium EDTA (0.1 g/liter), NaN3
(0.2 g/liter), and 0.05 mM PMSF, pH 7.0 (14). Usually seventy to eighty
8-ml fractions were collected. The absorbance at 280 nm was recorded
with a spectrophotometer (Beckman, Fullerton, CA; Model 24). After
addition of 5 ml of Bray scintillation solution to 0.1-ml aliquots of the
fractions, the ^-radiation emitted by [1,2-3H]cholesterol was measured
in a Betascint BF 5000 counter (BF-Vertriebs-GmbH, MÃ¼nchen,Federal
Republic of Germany). All fractions containing [1,2-3H]cholesterol were
pooled and concentrated to 3 to 5 ml. After rechromatography on a 120-
x 1.8-cm Biogel A-5m column, about fifty 8-ml fractions were collected.
Their counts per minute and the absorbance at 280 nm were plotted
graphically. The elution patterns revealed three peaks, each of which
was pooled and concentrated to 1 to 3 ml. They were the basis of the
following analysis.
After addition of NaN3 and PMSF, the fractionated ascites fluid sam
ples could be stored in a NaChEDTA buffer up to 6 wk at 4Â°C.Multiple
freezing and thawing as well as lyophilization denatured the protein
moiety and altered the immunological properties (15).
Recovery studies for triglycÃ©rides, cholesterol, and phospholipids re
vealed a loss of ascitic lipids of between 30 and 50% at the end of the
fractionation procedure.
Density Gradient Centrifugation. One-half ml of the sample was
added to 4.0 ml of CsCI solution (density, 1.070 g/ml). During 72 h of
ultracentrifugation at 4Â°Cand 50,000 rpm in a Beckman SW-60 rotor, a
concave gradient from 1.025 to 1.300 g/ml was established (16). Eleven
to twelve 0.4-ml fractions were obtained by pipeting from the top.
Densities were calculated by weighing 0.2-ml portions. The absorbance
at 280 nm and the counts per minute were measured in each fraction.
Electrophoresis. For SDS:polyacrylamide gel electrophoresis, ali
quots of the samples were diluted (1:4, v/v) with 0.31 M Tris-HCI buffer,
pH 6.8, containing SDS (2 g/dl), 2-mercaptoethanol (5 ml/dl), and glycerol
(10 ml/dl) (17). After incubation for 5 to 10 min at 100Â°Cand centrifuga-
tion for 2 min at 2000 rpm afterwards, the protein subunits were
separated on discontinuous vertical polyacrylamide gels (T = 3 and 10%;
C = 2.6%) at 20Â°C. The proteins were stained for 1 h with Coomassie
Blue R 250. Molecular weights were estimated by comparison with
calibration standards (Pharmacia, Freiburg, Federal Republic of Germany)
according to the method of Weber and Osbom (18). Densitometric scans
were performed with an Elscript 3 densitometer (Hirschmann, Unter-
haching, Federal Republic of Germany).
Electron Microscopy. Electron micrographs were taken with a Sie
mens 101 electron microscope at 80 kV.
The isolated proteinilipid complex was negatively stained with 2%
potassium phosphotungstate, pH 7.0 (19). A small drop of the suspension
was placed on a 200 or 300 Formavar carbon-coated grid and examined
after drying at room temperature.
Immunodif fusion. Ouchteriony immunodiffusion against anti-LSP was
performed in agarose (0.8 g/dl) in 0.01 M sodium phosphate-buffered
NaCI solution, pH 8.6, with and without SDS (0.5 to 1.0 g/dl). The plates
were incubated 24 to 48 h at 30Â°C. All other immunodiffusion studies
took place in Bacto-agar (2 g/dl; 0.02 M sodium diethylbarbiturate:0.03
M sodium acetate), pH 8.6, in the absence of SDS (20). The staining was
done with Amidoblack-10 B and Oilred 0 (Sigma, MÃ¼nchen,Federal
Republic of Germany). We tested against industrially produced and
purified antisera against human serum, human serum albumin, and a-
and f)-lipoproteins (Behring, Marburg, Federal Republic of Germany)
identical to apo-HDL and apo-LDL, respectively. Special antibodies
against cellular lipoproteins of the liver (anti-LSP) were made available
by U. Behrens, Veterans Administration Medical Center, Bronx, NY. LSP
was isolated 4 to 8 h postmortem from normal human liver that showed
neither autolysis nor any other significant histological changes (21).
Preparation was carried out at 4Â°C,observing exactly the instructions
of McFarlane ef al. (15). Antisera against the purified antigens were
produced in rabbits by repeated injections and absorbed with lyophilized
human plasma and tissue extracts at 37Â°C for 30 min (21). Organ
specificity was tested by double immunodiffusion, indirect immunofluo-
rescence, and immunoenzyme techniques.
RESULTS
After the determination of the protein and lipid concentrations
in ascites fluid (Table 1), the lower molecular proteins (Fig. 1,
second peak) were separated from protein-bound lipids (Fig. 1,
first peak) by gel filtration on a Sephadex G-100 column. The
elution profile showed rising absorbance at 280 nm coinciding
with elevated counts per minute in the first peak and high protein
absorbance without any evidence of radioactivity in the second
peak.
The calibration of the columns was performed with plasma
lipoproteins isolated by ultracentrifugation (22, 23). On Biogel A-
5m, VLDL eluted in the void volume, LDL represented a second
lower molecular peak, and HDL formed a third (Fig. 2a). Only a
slight overlap between LDL and HDL was detected by immuno
diffusion.
Rechromatography of the pooled and concentrated ascitic
protein:lipid fractions (Fig. 1, first peak) on the Biogel A-5m
column and recording the absorbance and the counts per minute
revealed three peaks resembling the calibration curve (Fig. 2b).
The first appeared in the void volume, indicating a molecular
weight of more than 5 million, compatible with very low density
lipoproteins. However, immunodiffusion studies were negative
against anti-a- and anti-0-lipoproteins, suggesting that the pres-
Table 1
Rangesand median valuesof lipid and protein concentrations in ascites fluid
listed in categories of neoplasms
TriglycÃ©rides
(mg/dl)
Total cholesterol
(mg/dl)
Phospholipids
(mg/dl)
Total protein (g/dl)Gastrointestinal
tract (n =7)"46.7-105.5(60.3)"
47.3-139.2(67.0)
21.6-77.8(62.4)
1.6-7.4(4.1)Carcinoma
oftheOvary
(n =9)36.0-104.1
(75.4)66.6-140.8
(131.0)
24.6-103.2(66.6)3.5-5.6
(4.4)Breast
(n =9)44.5-124.6(73.8)
51.1-214.9(84.9)
10.8-83.2(55.4)
2.7-6.0(3.8)a
Number of subjects.
6 Numbers in parentheses,median.
-2.0 >
i
-1.5 3-
-1.0
-0.5
M
00
O
100 200 300 400
Elution Volume [ml]
500
Fig. 1. Typicalgel Chromatographieelution profileof a concentratedascites fluid
samplefrom a patient with carcinomaof the stomach on SephadexG-100.Column
size, 100 x 2.5 cm. Points represent cpm emitted by [1,2-3H]cholesterol(A) and
the absorbance at 280 nm (O)recorded in each collected fraction. V0,void volume.
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Fig. 2. a, calibration curve of the Biogel A-5m column with ultracentrifugally
isolated lipoproteins. b, typical gel Chromatographie elution profile of the pooled
and concentrated ascitic lipidiprotein peak (Fig. 1) from a patient with carcinoma of
the stomach on Biogel A-5m. Column size, 120 x 1.8 cm. Points represent cpm
emitted by [1,2-3H]cholesterol (A) and the absorbance at 280 nm (O) in each
collected fraction. V0, void volume.
Table 2
Ranges and median values ol the percental lipid and protein composition of the
isolated ascitic protein-lipid complex listed in categories of neoplasms
%TriglycÃ©rides
Total cholesterol
PhospholipidsPEPC
PI
SM
Total proteinGastrointestinal
tract (n =if12.9-21.0(15.7)"
5.3-13.0 (7.2)
9.1-14.9 (9.8)
3.9
29.1
12.2
21.5
26.9
61.3-68.4(65.1)Carcinoma
oftheOvary
(n =9)16.4-23.1
(18.1)
1.8-8.2 (3.2)
7.9-14.3 (8.5)
1.2
13.8
30.8
17.3
32.6
59.3-67.8(64.1)Breast
(n =9)12.8-20.9(15.0)
5.9-14.5 (9.2)
2.9-11.4 (3.2)
2.3
17.2
34.3
11.5
29.8
62.8-69.7 (66.5)
a Number of subjects.
" Numbers in parentheses, median.
0 CL, cardiolipin; PE, ethanolamine glycerophospholipids; PC, phosphatidylcho-
line; PI, phosphatidylinositol; SM, sphingomyelin.
enee of plasma VLDL was unlikely.
The chemical analysis of the pooled and concentrated first
peak fractions showed the presence of 65.3% protein, 16.2%
triglycÃ©rides,7.4% phospholipids, and 7.0% cholesterol (median
values). The relative composition of these components listed in
categories of neoplasms is illustrated in Table 2. The phos-
pholipid moiety was further fractionated by quantitative thin-
layer chromatography in cardiolipin, ethanolamine glycerophos
pholipids, (lyso-)phosphatidylcholine, phosphatidylinositol, and
sphingomyelin.
An average density of 1.128 to 1.181 g/ml was determined by
CsCI gradient ultracentrifugation for the macromolecular pro-
tein:lipid complex (Fig. 3).
20-
â€¢15-
CN 10-
o
5-
-1.0 g"
o
I
-0.5 â€¢
Ã«
O
3
3
1.030 1.042 1.055 1.090 1.181 1.300
1.033 1.048 1.074 1.128 1.237
Density [g/cm3]
Fig. 3. Ultracentrifugai density determination of the isolated ascitic protein-lipid
complex from a patient with carcinoma of the gallbladder in a CsCI gradient (50,000
rpm for 72 h). Points represent cpm emitted by (1,2-3H]cholesterol (A) and the
absorbance at 280 nm (O) recorded in each fraction pipeted from the top.
For further characterization, proteins were separated by
SDS:PAGE, since the macromolecular complex did not penetrate
the gel completely in the absence of SDS. Up to 11 protein
subunits in a molecular weight range of 29,000 to 97,000 were
detected (Fig. 4). Band 5 showed identical mobility to human
serum albumin and was reduced by ultracentrifugation. The main
difference between various ascites fluid samples was varying
concentrations of corresponding subunits determined semiquan-
titatively by densitometric scans. No protein band specific for
certain types of carcinoma could be observed. Electron micros
copy revealed lipoprotein-like globular macromolecules with di
ameters of 36 to 64 nm (Fig. 5). An average molecular weight of
approximately 45 million was calculated.
In 21 of the 25 specimens there was a single precipitation line
against anti-LSP, suggesting identical antigenic determinants of
the macromolecular protein:lipid complex and cell membrane-
associated LSP (Fig. 6a). In the second peak, double radial
immunodiffusion showed precipitation lines against antiapo-LDL.
In the third peak a positive reaction with antiapo-HDL was seen
(Fig. 6, b and c). Table 3 presents the median values and ranges
of the percental lipid distribution on the three gel chromatograph-
ically separated peaks. The major amount of ascitic lipids was
found as low and high density lipoproteins.
DISCUSSION
The origin of high lipid concentrations in ascites fluid of patients
with neoplastia processes has not yet been clarified.
In our study the predominant part of ascitic lipids was re
covered as low and high density lipoproteins. On Biogel A-5m
columns, 61.1% of cholesterol, 49.7% of triglycÃ©rides, and
47.0% of phospholipids were eluted in the LDL fraction, and
21.9% of cholesterol, 29.5% of triglycÃ©rides, and 32.8% of
phospholipids appeared in the HDL molecular weight range
(median values). Antigenic identity with plasmatic apo-LDL and
apo-HDL was confirmed by Ouchteriony immunodiffusion. In
accordance with these findings, protein-associated ascitic lipids
similar to plasma lipoproteins have been described by Mathur
and Spector (2) and Malmendier (4). Abnormal capillary perme
ability is the main process of ascites fluid formation in peritoneal
carcinomatosis (24). Additional mechanisms are obstruction of
draining lymphatics or venous blockade. In this way plasma
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Fig.4. SDS:PAGE of the isolated macro-
molecular ascitic protein-lipid complex from a
patient with carcinoma of the pancreas in 3
different sample concentrations (lanes C to Â£)
on a 1.5-mm discontinuous polyacrylamidegel
(C = 2.6%; T = 3 and 10%). The standard
calibration kit (phosphorylaseb, M, 94,000; al
bumin, M, 67,000; ovalbumin, M, 43,000; car
bonic anhydrase,M, 30,000; and trypsin inhibi
tor, M, 20,100) is shown in LaneA. Left, molec
ular weights of subunits; right, semiquantitative
densitometric scan.
1 97000
2 93000
3 80000
4 74000
5 69000
6 57000
7 55000
8 51000
9 47000
10 42000
11 29000
Fig. 5. Electron microscopy of the isolated macromolecularascitic protein-lipid
complex from a patient with carcinoma of the breast using a Siemens 101 electron
microscope and a negative staining technique with 2% potassium phosphotungs-
tate, pH 7.O.x 140,000.
lipoproteins originating in the liver and intestine may be precur
sors of part of the ascitic lipoproteins (4, 5).
In addition to lipoproteins which were most likely of plasmatic
origin, we isolated a macromolecular protein-lipid complex re
sembling VLDL with respect to its molecular weight of about 45
million. However, in immunodiffusion studies, there was no proof
of anti-a- and anti-/3-lipoproteins. Identity with plasmatic very low
density lipoproteins could be excluded. The complex consisted
of 59.3 to 69.7% protein, 12.8 to 23.1% triglycÃ©rides, 2.9 to
14.9% phospholipids, and 1.8 to 14.5% cholesterol. Its varying
chemical composition is most likely caused by different extents
of partial delipidation during the isolation procedure. Most of the
lipids were lost during the Ultrafiltration, probably due to adher
ence or direct passage of free molecules originating from the
ascitic protein:lipid complex through the PM 10 membrane. The
permeation of the intact complex is not likely because of its size.
Less than 5% of lipids was retained in the included volume of
the gel chromatography columns. Ascites fluid filtration with a
Selecta No. 11171/2 filter did not have a significant influence on
the lipid recovery of 50 to 70%.
In accordance with the high protein content shown by CsCI
gradient ultracentrifugation, the ascitic protein-lipid complex
floated in the density range of 1.128 to 1.181 g/ml. SDS:PAGE
revealed up to 11 protein subunits. One of them was present in
about 40% of the samples and could be identified as albumin. It
was looked upon as a nonspecific contaminant, for its concen
tration was reduced considerably by ultracentrifugation. The first
peak electrophoretic patterns resembled each other regardless
of the underlying disease. The main differences were varying
concentrations of certain components. The total absence of
single bands in some specimens was probably caused by quan
tities below the detection limit. No subunits specific for certain
types of carcinomas were found. The possible reason is the
general peritoneal carcinomatosis common to every patient of
the study.
The macromolecular protein-lipid complex showed a single
precipitation line with anti-LSP. Twenty-one of 25 ascites fluid
samples reacted immunologically with anti-LSP. This might be
explained by the lability of the protein:lipid complex (15) or by
concentrations not detectable by the methods applied.
LSP is present in the 105,000 x g supernatant of human liver
homogenates. Using molecular sieving techniques, a molecular
weight of more than 4 million was determined. The existence of
higher molecular aggregates could not be excluded (15). In the
ultracentrifugation gradient, LSP floated in a density range of
1.107 to 1.188 g/ml (21). Protein analysis by SDS:PAGE revealed
8 to 13 subunits ranging from 40,000 to 96,000. One of them
showed the same electrophoretic mobility as albumin. Its con
centration could be diminished by rechromatography but was
not eliminated completely. Most likely it is not part of the apopro-
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C.
allowed the identification of LSP as a part of the surface mem
brane of the cell (21, 27).
Considering the many similarities despite the different isolation
procedures and method-related inaccuracies, a close relationship
of the ascitic protein:lipid complex and LSP is very likely. The
presence of LSP in ascites fluid could be caused by peritoneal
carcinomatosis, which led to accumulation of cell membrane
proteolipids in the peritoneal effusion. This is no proof that the
macromolecular protein:lipid complex is especially associated
with cancer. In other body fluids, comparable proteolipids of
cellular origin have been described in the absence of neoplastic
processes (28). However, in ascitic fluid of patients with chronic
liver disease, this complex could not be found, possibly due to
minor concentrations not detectable with the methods used.
In conclusion, major amounts of ascitic lipids were found as
low and high density lipoproteins probably originating from
plasma. However, macromolecular protein-lipid complexes de
rived from cell membranes of the peritoneum by carcinomatosis
contribute to the total lipids in malignant ascites fluid.
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Fig. 6. a, immunodiffusion of the gel chromatographically isolated ascitic protein-
lipid complex from a patient with carcinoma of the ovary (Wells 2, 4, and 6) in
agarose (0.8 g/dl) in 0.01 M sodium phosphate-buffered NaCI solution, pH 8.6, with
SDS (0.5 to 1.0 g/dl) against anti-LSP (Wells 1,3,5, and 7). b, immunodiffusion of
the gel chromatographically isolated, pooled, and concentrated second peak frac
tions (Fig. 20) from a patient with carcinoma of the ovary (Well 1) against antiapo-
LDL (Wells 2 and 3); and c, that of the pooled and concentrated third peak fractions
(Fig. 20) from a patient with carcinoma of the ovary (Well 4) against antiapo-HDL
(Wells 5 and 6). Immunodiffusion was performed in Bacto-agar (0.2 g/dl), 0.02 M
sodium diethylbarbiturate, and 0.03 M sodium acetate, pH 8.6. The lipoproteins
were stained with Amidoblack-1 OB and Oilred 0 (Â£>and c).
Table 3
Ranges and median values of the percental lipid distribution on the three gel
chromatographically fractionated peaks on Biogel A-5m (n = 25 patients)
Macromolecular pro
tein-lipid fraction
(Peak 1)
LDL fraction
(Peak 2)
HDL fraction
(Peak 3)
Total cholesterol
TriglycÃ©rides
Phospholipids
2.3-30.9 (11.4)"
1.7-37.5(24.2)
1.5-28.7(12.4)
32.1-79.9(61.1)
32.4-81.3 (49.7)
29.2-79.7 (47.0)
11.2-43.9 (21.9)
17.4-43.5(29.5)
13.0-47.6(32.8)
8 Numbers in parentheses, median.
tein (15). In contrast to former opinions (25), LSP was found not
to be organ specific. Behrens and Paronetto (21) produced anti-
LSP sera in rabbits which reacted with membranes of liver cells
and also of intestine, smooth muscle, spleen, and kidney. These
findings were supported by Murakami ef al. (26) who were not
able to establish a cell line producing monoclonal antibodies
exclusively against liver cell membranes. Indirect immunofluores-
cence and immunoenzyme light microscopy on cryostat sections
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